In agreement, we herein observed that concurrent dual therapy with Ad-ΔB/TRAIL and Ad-ΔB/IL-12 had resulted in profound promotion of apoptosis in both HCC cells (as indicated by flow cytometry analysis) and in tumor tissues (as observed by TUNEL assay). The gene discussed is TNFSF10; the disease is hepatocellular carcinoma.